Union Pacific on Pace for Largest Percent Decrease Since February 2023 — Data Talk
Union Pacific Corporation (UNP) is currently at $229.65, down $6.64 or 2.81%
--On pace for largest percent decrease since Feb. 21, 2023, when it fell 3.89%
--Snaps a four day winning streak
--Down 6.62% month-to-date; on pace for worst month since Sept. 2023, when it fell 7.68%
--Down 6.5% year-to-date
--Down 17% from its all-time closing high of $276.69 on March 30, 2022
--Up 19.92% from 52 weeks ago (April 26, 2023), when it closed at $191.50
--Down 10.61% from its 52-week closing high of $256.91 on Feb. 23, 2024
--Up 19.92% from its 52-week closing low of $191.50 on April 26, 2023
--Traded as low as $229.32
--Down 2.95% at today's intraday low; largest intraday percent decrease since July 27, 2023, when it fell as much as 3.19%
All data as of 12:19:54 PM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
April 24, 2024 12:37 ET (16:37 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks